A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

Clinical trial NCT01387087 · COMPLETED

Trial details

NCT number: NCT01387087
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of ASP015K

Start date: 2008-07-01
Primary completion: 2008-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.